AR133276A1 - Nuevos derivados de pirazolopiridina - Google Patents

Nuevos derivados de pirazolopiridina

Info

Publication number
AR133276A1
AR133276A1 ARP240101857A ARP240101857A AR133276A1 AR 133276 A1 AR133276 A1 AR 133276A1 AR P240101857 A ARP240101857 A AR P240101857A AR P240101857 A ARP240101857 A AR P240101857A AR 133276 A1 AR133276 A1 AR 133276A1
Authority
AR
Argentina
Prior art keywords
pyrazolopyridine derivatives
new pyrazolopyridine
new
derivatives
compound
Prior art date
Application number
ARP240101857A
Other languages
English (en)
Inventor
Ld Stefan Berchto
Julie Charpentier
Hlose Marie Albine Colombano
Guillaume Dcoret
Zbinden Katrin Groebke
Nicole Grossmann
Wolfgang Haap
Lukas Kreis
Cabr Xavier Lucas
Philippe Pflieger
Etienne Rauber
Jean Wach
- Wermuth Roger Yves
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR133276A1 publication Critical patent/AR133276A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención se refiere a un compuesto de fórmula (1) o (2), en donde L, R¹, R², R³ y R⁴ son como se definen en la descripción y en las reivindicaciones. El compuesto de fórmula (1) o (2) puede usarse como medicamento.
ARP240101857A 2023-07-19 2024-07-17 Nuevos derivados de pirazolopiridina AR133276A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP23186306 2023-07-19

Publications (1)

Publication Number Publication Date
AR133276A1 true AR133276A1 (es) 2025-09-10

Family

ID=87418816

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP240101857A AR133276A1 (es) 2023-07-19 2024-07-17 Nuevos derivados de pirazolopiridina

Country Status (6)

Country Link
EP (1) EP4746964A1 (es)
JP (1) JP2026525061A (es)
CN (1) CN121693503A (es)
AR (1) AR133276A1 (es)
TW (1) TW202510868A (es)
WO (1) WO2025017078A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026046976A1 (en) * 2024-08-27 2026-03-05 F. Hoffmann-La Roche Ag Pyrazolopyridine phosphate esters for modulating salt-inducible kinase (sik)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012516329A (ja) * 2009-01-30 2012-07-19 ミレニアム ファーマシューティカルズ, インコーポレイテッド Pi3k阻害剤としてのヘテロアリールおよびその使用
GB201907558D0 (en) * 2019-05-29 2019-07-10 Galapagos Nv Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
CN115197208A (zh) * 2021-04-01 2022-10-18 江苏恒瑞医药股份有限公司 杂芳基类化合物、其制备方法及其在医药上的应用
CN115677690A (zh) * 2021-07-30 2023-02-03 江苏恒瑞医药股份有限公司 杂芳基类化合物、其制备方法及其在医药上的应用
CN118119619A (zh) * 2021-10-18 2024-05-31 上海美悦生物科技发展有限公司 Sik抑制剂及其组合物、制备方法和用途

Also Published As

Publication number Publication date
JP2026525061A (ja) 2026-07-27
WO2025017078A1 (en) 2025-01-23
EP4746964A1 (en) 2026-05-27
TW202510868A (zh) 2025-03-16
CN121693503A (zh) 2026-03-17

Similar Documents

Publication Publication Date Title
UY38448A (es) Compuestos de azol-amida pesticidamente activos
AR133028A1 (es) Composición farmacéutica que comprende un degradador de todas las kras
CL2022001529A1 (es) Nuevos derivados de metilquinazolinona
CL2021002519A1 (es) Compuestos de diazina-amida activos como pesticidas.
CR20230115A (es) Compuestos heterocíclicos
MX2021012162A (es) Compuestos de diazina-amida activos como pesticidas.
PY1923494A (es) Derivados de n-(3-(7h-pirrolo[2,3-d]pirimidin-4-il)fenil)benzamida
UY37623A (es) Derivados de oxadiazol tiofeno fungicidas
EA200401167A1 (ru) Производные тропана в качестве модуляторов ccr5
AR116283A1 (es) Inhibidores del sarcómero cardíaco
ECSP22030481A (es) Compuestos de amina cíclica activos como plaguicidas
UY35295A (es) ?Compuestos microbicidas novedosos, métodos para su uso y composiciones?.
CL2020003331A1 (es) Nuevos compuestos de piridina y pirazina como inhibidores del receptor cannabinoide 2
MX2022001161A (es) Derivados de 3,6-diamino-piridazin-3-ilo, composiciones farmaceuticas que los contienen y sus usos como agentes proapoptoticos.
MX2023013719A (es) Nuevas piridinas sustituidas como fungicidas.
CL2022001353A1 (es) Inhibidores de egfr
CO2024010453A2 (es) Nuevos derivados de benzimidazol piridina
DOP2023000209A (es) Compuestos heterocíclicos de arilo como bloqueadores del canal agitador de potasio kv1.3
AR121598A1 (es) Compuesto de oxazolidinona y métodos de uso de este como agente antibacteriano
AR088982A1 (es) Derivados de 2-yodo-imidazol
CR20200618A (es) Derivados de tetrahidrotienopiridina n-sustituidos y sus usos
MX2024012874A (es) Antagonistas ccr4
AR127023A1 (es) Nuevos derivados de quinolina
CO2024010803A2 (es) Compuestos de tienopirrolotriazina, su preparación y su uso terapéutico
CR20180615A (es) Nuevos derivados de [1,2,3]triazol[4,5-d]pirimidina

Legal Events

Date Code Title Description
FB Suspension of granting procedure